Previous 10 | Next 10 |
Mesoblast (MESO) -37% after FDA rejects cell therapy application for treatment-resistant graft-vs-host disease.Benitec Biopharma (BNTC) -26%.Greenpro Capital (GRNQ) -18%.Tuniu (TOUR) -14%.Hall of Fame Resort & Entertainment (HOFV) -13%.Iterum Therapeutics (ITRM) -12%.Oxbridge Re...
Gainers: Solid Biosciences (SLDB) +114%.Enlivex Therapeutics (ENLV) +45%.AMAG Pharmaceuticals (AMAG) +45%.American Equity Investment Life (AEL) +40%.Gridsum (GSUM) +36%.Bed Bath & Beyond (BBBY) +33%.Watford Holdings (WTRE) +26%.Advanced Emissions Solutions (ADES) +25%.Westwater Resou...
Benitec (BNTC): FY GAAP EPS of -$8.10.Revenue of $0.1M (-99.2% Y/Y)Press Release For further details see: Benitec reports FY results
Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif., Sept. 23, 2020 HAYWARD, Calif. , Sept. 23, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Co...
HAYWARD, Calif. , Sept. 1, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that ...
HAYWARD, Calif. , July 8, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced the...
Gainers: Cyclacel Pharmaceuticals (NASDAQ: CYCC ) +91% . More news on: Cyclacel Pharmaceuticals, Inc., Benitec Biopharma Limited, VBI Vaccines Inc., Stocks on the move, , Read more ...
Benitec Biopharma Limited (NASDAQ: BNTC ) initiated with Buy rating and $14 (140% upside) price target at Ladenburg Thalmann. More news on: Benitec Biopharma Limited, AbbVie Inc., Gilead Sciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
HAYWARD, Calif. , April 14, 2020 /PRNewswire/ -- Benitec Biopharma, Inc., a successor entity to Benitec Biopharma Limited (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today announced the appointment of Edward Smit...
MELBOURNE, Australia , March 30, 2020 /PRNewswire/ -- Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group fr...
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
Benitec Biopharma Limited Website:
2024-07-16 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the 180-day post-dose assessment following the administration of the low dose of gene therapy BB-301 as ...
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace ...